Key Record Dates
ClinicalTrials.gov Identifier: | NCT04616534 |
---|---|
Brief Title: | Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors |
First Submitted : | November 4, 2020 |
First Submitted that Met QC Criteria : | November 4, 2020 |
First Posted : | November 5, 2020 |
Last Update Submitted that Met QC Criteria : | April 6, 2024 |
Last Update Posted : | April 9, 2024 |